Université de Versailles-Saint-Quentin, France
Author Profile
Scopus
Early Academic Pursuits 🎓
Professor Breban embarked on his medical journey at Paris hospitals, earning his Doctor of Medicine (MD) degree between 1984 and 1990. His passion for immunology and rheumatology led him to pursue a Doctorate (PhD), which he completed in 1994 under the auspices of the French National Institute for Medical Research. During this period, he honed his expertise in immuno-rheumatology, laying a solid foundation for his future endeavors.igasconference.com
Professional Endeavors 🏥
Following his PhD, Professor Breban undertook a post-doctoral fellowship at the Harold Simmons Research Center, University of Texas, Dallas, USA, from 1990 to 1993, under the mentorship of Professor Joel D. Taurog. This international experience enriched his research perspective and expertise. Upon returning to France, he served as a clinical fellow and subsequently as Associate Professor of Immunology at Cochin Hospital, Paris, from 1993 to 2002. In 2002, he joined the Rheumatology Division of Ambroise Paré Hospital in Boulogne-Billancourt as a Professor of Rheumatology and ascended to the role of Head of the Department in 2011. Concurrently, he has been directing a research team focused on chronic inflammation in rheumatic disorders, which transitioned from the Cochin Institute to the Faculty of Simone Veil-Santé in 2013. igasconference.com
Contributions and Research Focus 🔬
Professor Breban’s research primarily centers on the immunogenetics of ankylosing spondylitis and related spondyloarthritis. He has been the principal investigator and coordinator for numerous clinical and basic research projects. Over the past two decades, he has contributed to over 100 original papers and 40 review articles in the field of SpA. His work has significantly advanced the understanding of the genetic and environmental factors contributing to SpA, including the role of the microbiome in disease pathogenesis. igasconference.com
Accolades and Recognition 🏆
Throughout his illustrious career, Professor Breban has received several prestigious awards, including the American College of Rheumatology Fellowship Award for Excellence in Scientific Research in 1992 and the Guillaumat-Piel Prize from the Foundation for Medical Research in 2018. These accolades underscore his substantial contributions to rheumatology research and his dedication to advancing medical science. igasconference.com
Impact and Influence 🌍
Professor Breban’s influence extends beyond his research contributions. He has played pivotal roles in various scientific committees and societies, including serving as President of the Scientific Committee of the French Rheumatology Society from 1998 to 2004 and as a member of the Scientific Board of the French National Research Agency from 2012 to 2013. His involvement in these organizations has shaped research agendas and fostered collaborations within the rheumatology community.
Legacy and Future Contributions 🚀
As a dedicated educator, Professor Breban has been imparting knowledge in rheumatology to medical students since 1993 and has been involved in various master’s programs and university diplomas related to immunology and rheumatology. His commitment to teaching ensures the cultivation of future generations of rheumatologists. Looking ahead, Professor Breban continues to lead research initiatives aimed at unraveling the complexities of chronic inflammatory diseases, with the goal of developing innovative therapeutic strategies and improving patient outcomes.
In summary, Professor Maxime Breban’s career is marked by a profound dedication to the study and treatment of rheumatic diseases. His extensive research, leadership roles, and commitment to education have left an indelible mark on the field of rheumatology, promising continued advancements in understanding and managing these complex conditions.
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis
Authors: M. Beaufrère, Marie; M. Jacoutot, Manon; M.A. Breban, Maxime A.; S. Glatigny, Simon
Journal: Journal of Autoimmunity
Year: 2025
Microbiota in spondyloarthritis: Where are we?
Authors: M.A. Breban, Maxime A.; M. Beaufrère, Marie; M. Jacoutot, Manon; S. Glatigny, Simon
Journal: Not provided
Year: Not provided
What is a severe axial spondyloarthritis?
Authors: F. Costantino, Félicie; M.A. Breban, Maxime A.; M.A. D’Agostino, Maria Antonietta
Journal: Not provided
Year: Not provided
TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis
Authors: M. Lauraine, Marc; M. de Taffin de Tilques, Maxence; D. Melamed-Kadosh, Dganit; L.M. Araujo, Luiza M.; M.A. Breban, Maxime A.
Journal: Arthritis Research and Therapy
Year: 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop
Authors: D. Wendling, Daniel; M.A. Breban, Maxime A.; F. Costantino, Félicie; F.M. Verhoeven, Frank M.; C. Prati, Clément
Journal: Not provided
Year: Not provided